1. Home
  2. BOW vs XNCR Comparison

BOW vs XNCR Comparison

Compare BOW & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$22.45

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.96

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
XNCR
Founded
2020
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
881.9M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
BOW
XNCR
Price
$22.45
$11.96
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$34.29
$22.89
AVG Volume (30 Days)
217.8K
644.9K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
23.26
65.36
EPS
1.59
N/A
Revenue
$551,589,000.00
$125,576,000.00
Revenue This Year
$21.14
N/A
Revenue Next Year
$19.15
$6.52
P/E Ratio
$14.11
N/A
Revenue Growth
29.58
13.65
52 Week Low
$21.93
$6.92
52 Week High
$42.29
$18.69

Technical Indicators

Market Signals
Indicator
BOW
XNCR
Relative Strength Index (RSI) 34.17 48.51
Support Level $22.15 $10.92
Resistance Level $26.45 $12.73
Average True Range (ATR) 1.17 0.90
MACD -0.26 0.04
Stochastic Oscillator 12.04 34.18

Price Performance

Historical Comparison
BOW
XNCR

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: